Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Neostigmine vs Ketamine as Adjuvants in TAP Block for C-Section
NCT06871033Phase 3Completed
- Sponsor
- Alexandria University
- Start
- Jan 2024
- Primary completion
- Dec 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of neostigmine in postoperative pain (2 arms), sponsored by Alexandria University. Primary endpoint: Post operative pain score (VAS) at 24 hours. Started Jan 2024; status: completed.
02
Drugs
neostigmine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT06871033.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06871033.